A Randomized, Double‐Blind, Placebo‐Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Use Disorder and Pathological Gambling
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The efficacy of naltrexone as a treatment for concurrent alcohol abuse or dependence and pathological gambling was evaluated in a randomized, double‐blind, placebo‐controlled trial. Fifty‐two, mostly male, subjects were recruited from the community and received 11 weeks of medication during which cognitive‐behavioral counseling was also provided. No significant group differences were found on any alcohol or gambling variable (ie, frequency, quantity, expenditures) at post‐treatment or at the one year follow‐up. However, a strong time effect was found suggesting that treatment, in general, was effective. The use of naltrexone to treat concurrent alcohol use and gambling problems was not supported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Pathological gambling: Etiology, comorbidity, and treatment.
Petry, N. M. (2005) · doi:10.1037/10894-000 · Cited by 659
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618 · cited 2×
“While the evidence for naltrexone is generally positive, there are studies that have reported mixed results or no differences from placebo response (e.g., Balldin et al., 2003; Froehlich, O’Malley, Hyytia, Davidson, & Farren, 2003; Krystal et al., 2001; Chick et al., 2000), and there is continuing discussion about the…”
BackgroundResultAn fMRI Stroop Task Study of Ventromedial Prefrontal Cortical Function in Pathological Gamblers
Potenza, M. N., Leung, H.-C., Blumberg, H. P., Peterson, B. S., Fulbright, R. K., Lacadie, C. M., Skudlarski, P., & Gore, J. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1990 · Cited by 400
Motivational enhancement and self-help treatments for problem gambling
Hodgins, D. C., Currie, S. R., & el-Guebaly, N. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.1.50 · Cited by 299
Assessing and treating problem gambling: Empirical status and promising trends
Toneatto, T., & Millar, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900803 · Cited by 116
Self-citationMilton, S., Crino, R., Hunt, C., & Prosser, E. (2002) · Journal of Gambling Studies · doi:10.1023/a:1015580800028 · Cited by 103
Cited by
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470
Hodgins, D. C., Stea, J. N., & Grant, J. E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62185-x · Cited by 452
Leeman, R. F., & Potenza, M. N. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2550-7 · Cited by 448
Impulse Control Disorders: Updated Review of Clinical Characteristics and Pharmacological Management
Schreiber, L., Odlaug, B. L., & Grant, J. E. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00001 · Cited by 290
Behavioral Addictions as Mental Disorders: To Be or Not To Be?
Petry, N. M., Zajac, K., & Ginley, M. K. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045120 · Cited by 254
“One study of an opioid antagonist, nalmafene, found some benefits relative to placebo (Grant et al. 2006), but follow-up studies yielded no advantage (Grant et al. 2010, Toneatto et al. 2009).”
Metadata
- Authors
- Toneatto, T., Brands, B., & Selby, P.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2009-05-06
- Volume
- 18
- Issue
- 3
- Pages
- 219-225
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W2111432324
- Cited by
- 64
- References
- 7
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.